OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator. This document is also available as Markdown.

2023-12-31-accounts

REGISTERED COMPANY NUMBER: CE008950 (England and Wales) REGISTERED CHARITY NUMBER: 1171373

Report of the Trustees and

Audited Financial Statements

for the Year Ended 31 December 2023

for

British Skin Foundation

==> picture [108 x 112] intentionally omitted <==

Nichols & Co ( Accountancy ) Limited Chartered Accountants and Statutory Auditors Unit 7 Mulberry Place Pinnell Road Eltham London SE9 6AR

British Skin Foundation

Contents of the Financial Statements for the Year Ended 31 December 2023

Page
Reference and Administrative Details 1
Report of the Trustees 2 to 4
Report of the Independent Auditors 5 to 6
Statement of Financial Activities 7
Balance Sheet 8
Cash Flow Statement 9
Notes to the Financial Statements 10 to 20

British Skin Foundation

Reference and Administrative Details for the Year Ended 31 December 2023

TRUSTEES

Mrs E Erkal-Paler Chair Person Professor C B Bunker Honorary Secretary Professor D J Gawkrodger Honorary Treasurer Mr H Drayton Professor R Sarkany Dr S Mayou Professor E Healy Mr R Balson Dr B Shergill Dr T Griffiths (resigned 9.5.24) Mrs Y Burne Dr N Rajan Professor M Ardern-Jones (appointed 9.5.24)

REGISTERED OFFICE

4 Fitzroy Square London W1T 5HQ

REGISTERED COMPANY NUMBER

CE008950 (England and Wales)

REGISTERED CHARITY 1171373 NUMBER

AUDITORS Nichols & Co ( Accountancy ) Limited Chartered Accountants and Statutory Auditors Unit 7 Mulberry Place Pinnell Road Eltham London SE9 6AR

Page 1

British Skin Foundation

Report of the Trustees for the Year Ended 31 December 2023

The trustees present their report and the audited financial statements of the charity for the year ended 31 December 2023. The trustees have adopted the provisions of the Statement of Recommended Practice (SORP) "Accounting and Reporting by Charities" in preparing the annual report and financial statements of the charity.

OBJECTIVES AND ACTIVITIES

The Trust was set up in order to raise funds and provide funds, either directly or by way of grants, to others for the purpose of research into dermatology and the causes of skin diseases and the possibilities of prevention, alleviation, and cure.

ACHIEVEMENTS AND PERFORMANCE

2023 was the most financially successful year the British Skin Foundation (BSF) ever had with income approaching £2 million for the first time ever. Increases were seen in almost all of the BSF’s charitable income streams. These financial successes were matched by similar growth in BSF’s public and media profile as more people turned to the charity as a trusted source of skin information and opinion.

The BSF’s strong financial stability enabled it to deliver an extensive research grants programme throughout 2023, culminating in a very successful large grants distribution in late November. General overheads remained within budget and salary expenditure represented a respectable 16% of the BSF’s overall revenue. This percentage is well below the expectation for a charity of the BSF’s size and illustrates efficiency.

BSF’s income was up an impressive 40% on 2022’s figures, with corporate donations, its largest income source, peaking at an impressive £568,773. In addition, several pharmaceutical donors sought to support the BSF with various educational initiatives, further securing the BSF’s public profile in the field of skin health and disease. Well-known names such Boots also chose to donate to the BSF’s work after recognizing its place in educating the public around skin health.

Public and events fundraising remained sluggish during 2023. This was mainly due to the cost of living crisis and the public’s reticence to get involved in fundraising when it's a tough financial climate. This position is not unique to the BSF with many across the 3rd sector experiencing similar difficulties. Events income of £42,414 was lower than 2022, but in line with expectations. There are plans to build on these figures in 2024 through some big initiatives such as spaces in the London Marathon and by attracting corporate supporters to consider making the BSF the charity of choice for their employees.

Legacy income for the year was an impressive £55,775, illustrating that the BSF’s awareness efforts in this area over recent decades are now delivering regular gifts. The BSF is hoping to build on these successes by committing resources to this potentially important source of funding and hopefully seeing increases in the years to come.

Support from the dermatology specialty continued in 2023, especially donations from the British Association of Dermatologists (BAD). Financially BAD donated a further £256,000 towards the BSF’s work, on top of its small and specific grants support. BAD’s support is wider than financial, it gives the BSF a powerful platform and voice to the dermatological community. Together both organisations will be supporting Professor Sinead Langan in 2024’s London Marathon so collectively it is hoped the whole dermatology community will get behind her efforts and raise as much money as possible for skin disease research.

Another important stakeholder, the Skin Health Alliance, donated a further £200,900 to the BSF in 2023. Reflecting the needs and wishes of its own stakeholders and funders it asked that £100,000 of this donation be earmarked for a specific research project into the psychological impact of skin disease in 2024.

The BSF delivered a broad and generous grants programme in 2023 totalling over £1.1 million. An impressive £100,000 of small grants were awarded in the summer with a further £1 million being spent on large grants in November. Research projects supporting many skin conditions and skin cancer at many universities and medical schools were funded.

In communications, media and PR, BSF’s messages continued to be amplified throughout 2023. BSF Communications team has become the first point of contact for the media for opinion and comment on all skin issues. Staffing and resources were increased in this area to meet this growing demand for trustworthy and expert information. Many corporate supporters also see the BSF’s impartiality as an asset when communicating to the public or their consumers. The BSF created a variety of patient and consumer focused educational projects across many platforms.

Page 2

British Skin Foundation

Report of the Trustees

for the Year Ended 31 December 2023

2023 saw the BSF deliver on many of the initiatives set out in the first year of its 3-year business plan, one that seeks to amplify its efforts in communications, fundraising and grant giving. The BSF’s voice remains loud and relevant in what is becoming a very crowded skin health space. More people than ever are hearing its name and associate it with trustworthy advice and information. They are then choosing to support the BSF’s charitable objectives allowing it to fund even more dermatologist-led skin disease and skin cancer research in the future.

FUNDRAISING STANDARD INFORMATION

As a registered charity funding skin disease and skin cancer research, British Skin Foundation actively fundraises by canvassing support from the public, industry, and philanthropic trusts. Its fundraising activities are undertaken by employed staff without the use of external third party fundraisers. These staff work within the guidelines set out by the Charity Commission and within the parameters of the charity's own fundraising policy. During this accounting period, the charity has received no complaints pertaining to its fundraising practices or its staff. The charity does not cold call or place pressure on donors to give and it does use third parties or professional fundraising companies to attract support.

PUBLIC BENEFIT

The trustees have referred to the guidance contained in the Charity Commission's guidance on public benefit when reviewing the charity's aims and objectives and in planning its future activities. In particular, the trustees consider how planned activities will contribute to the aims and objectives that have been set.

STRATEGIC REPORT

FINANCIAL REVIEW

The charity's principal sources of funding are donations and legacies. The assets of the charity are mainly held in norisk investment accounts at four unrelated British financial institutions. The assets are held in cash because the charity needs ready access to funds to meet grant commitments. The charity has also invested £150,000 (2022: £150,000) in a listed investment fund and are monitoring its performance.

RESERVES POLICY

The British Skin Foundation will maintain sufficient reserves to ensure financial stability. Each year monies which are not already committed to reserves or grants, or required for running the organisation, will be made available for new awards. As there is always a delay between the granting of awards and the call for funds, a substantial positive balance will remain in the bank. If there are insufficient suitable applications for grants, the monies will be carried over to the next year.

Unrestricted funds invested in tangible fixed assets, listed investments and cash increased from £2,693,087 to £3,039,057 during the year. Restricted funds invested in cash increased from £255,664 to £617,855 during the year.

STRUCTURE, GOVERNANCE AND MANAGEMENT

Governing document

The charitable incorporated organisation ("CIO") was registered with the Charity Commissioners by Trust Deed on 30th January 2017 under the name "British Skin Foundation". The CIO has taken over the activities of the charity "The British Skin Foundation" (registered charity number 313865) on the 5th June 2020, as part of a restructuring of the charity.

New trustees may be appointed at any time either by way of replacement or addition. Appointments are made by a resolution of a meeting of the trustees provided that a memorandum declaring such appointment or discharge shall be signed as a deed either at a meeting by the person presiding or in some other manner directed by the meeting and attested by two persons present at the meeting.

Trustees are recruited either on personal recommendation or, where appropriate, through advertising. Care is taken to maintain a balance between the business and medical experience and skills contributed by the trustees. References are taken up on potential trustees and they are required to attend a briefing on the charity's activities given by the administrator, where they are provided with background information, copies of the latest audited accounts, and the latest Charity Commission guidance.

Page 3

British Skin Foundation

Report of the Trustees for the Year Ended 31 December 2023

The trustees oversee the pay and remuneration of the CEO Matthew Patey which is benchmarked against industry standards and based upon performance and an annual review.

The trustees have reviewed the major risks facing the charity and taken action to manage those risks. The major risks are a fall in income due to difficulties in the corporate and financial markets and possible employee fraud. The possibility of fraud is minimised by only the trustees being signatories on the bank accounts, and robust bank account security. In addition, the Trustee Indemnity Insurance Policy includes cover against possible employee fraud.

Key management remuneration

The total amount of employee benefits (including employer pension contributions) received by key management personnel for their services to the Charity was £71,711 (2022: £76,305).

STATEMENT OF TRUSTEES' RESPONSIBILITIES

The trustees are responsible for preparing the Report of the Trustees and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

The law applicable to charities in England & Wales requires the trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charity and of the incoming resources and application of resources of the charity for that period.

In preparing these financial statements, the trustees are required to:

The trustees are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the charity and enable them to ensure that the financial statements comply with the Charities Act 2011, the Charities (Accounts and Reports) Regulations 2008 and the provisions of the trust deed. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

The trustees are responsible for the maintenance and integrity of the charity and financial information included on the charity's website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

Report of the trustees approved by order of the board of trustees on ............................................. and signed on the board's behalf by:

........................................................................ Professor C B Bunker - Trustee

Page 4

Report of the Independent Auditors to the Trustees of British Skin Foundation

Opinion

We have audited the financial statements of British Skin Foundation (the 'charitable company') for the year ended 31 December 2023 which comprise the Statement of Financial Activities, the Balance Sheet, the Cash Flow Statement and notes to the financial statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the charitable company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the trustees' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charitable company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.

Other information

The trustees are responsible for the other information. The other information comprises the information included in the Annual Report, other than the financial statements and our Report of the Independent Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Matters on which we are required to report by exception

We have nothing to report in respect of the following matters where the Charities (Accounts and Reports) Regulations 2008 requires us to report to you if, in our opinion:

Responsibilities of trustees

As explained more fully in the Statement of Trustees' Responsibilities, the trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

Page 5

Report of the Independent Auditors to the Trustees of British Skin Foundation

In preparing the financial statements, the trustees are responsible for assessing the charitable company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so.

Our responsibilities for the audit of the financial statements

We have been appointed as auditors under Section 144 of the Charities Act 2011 and report in accordance with the Act and relevant regulations made or having effect thereunder.

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Independent Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The specific procedure for this engagement and the extent to which these are capable of detecting irregularities, including fraud is detailed below:

Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Independent Auditors.

Use of our report

This report is made solely to the charitable company's trustees, as a body, in accordance with Part 4 of the Charities (Accounts and Reports) Regulations 2008. Our audit work has been undertaken so that we might state to the charitable company's trustees those matters we are required to state to them in an auditors' report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and the charitable company's trustees as a body, for our audit work, for this report, or for the opinions we have formed.

Nichols & Co ( Accountancy ) Limited Chartered Accountants and Statutory Auditors Eligible to act as an auditor in terms of Section 1212 of the Companies Act 2006 Unit 7 Mulberry Place Pinnell Road, Eltham London SE9 6AR

Date: .............................................

Page 6

British Skin Foundation

Statement of Financial Activities

for the Year Ended 31 December 2023

Unrestricted
fund
Notes
£
INCOME AND ENDOWMENTS FROM
Donations and legacies
2
1,240,401
Other trading activities
3
54,914
Investment income
4
17,713
Total
1,313,028
EXPENDITURE ON
Raising funds
5
15,485
Charitable activities
6
Charitable Activities
871,548
Support Costs
85,518
Total
972,551
NET INCOME
340,477
Other recognised gains/(losses)
Gains/(losses) on revaluation of fixed assets
5,493
Net movement in funds
345,970
RECONCILIATION OF FUNDS
Total funds brought forward
2,693,087
TOTAL FUNDS CARRIED FORWARD
3,039,057
Restricted
fund
£
543,472
-
-
543,472
-
181,281
-
181,281
362,191
-
362,191
255,664
617,855
31.12.23
Total
funds
£
1,783,873
54,914
17,713
1,856,500
15,485
1,052,829
85,518
1,153,832
702,668
5,493
708,161
2,948,751
3,656,912
31.12.22
Total
funds
£
1,268,978
53,499
6,701
1,329,178
6,993
962,612
81,786
1,051,391
277,787
(15,031)
262,756
2,685,995
2,948,751

CONTINUING OPERATIONS

All income and expenditure has arisen from continuing activities.

The notes form part of these financial statements

Page 7

British Skin Foundation

Balance Sheet

31 December 2023

Unrestricted
fund
Notes
£
FIXED ASSETS
Tangible assets
14
7,994
Investments
15
151,632
159,626
CURRENT ASSETS
Debtors
16
147,177
Cash at bank and in hand
2,916,802
3,063,979
CREDITORS
Amounts falling due within one year
17
(184,548)
NET CURRENT ASSETS
2,879,431
TOTAL ASSETS LESS CURRENT
LIABILITIES
3,039,057
NET ASSETS
3,039,057
FUNDS
18
Unrestricted funds
Restricted funds
TOTAL FUNDS
Restricted
fund
£
-
-
-
-
662,431
662,431
(44,576)
617,855
617,855
617,855
31.12.23
Total
funds
£
7,994
151,632
159,626
147,177
3,579,233
3,726,410
(229,124)
3,497,286
3,656,912
3,656,912
3,039,057
617,855
3,656,912
31.12.22
Total
funds
£
8,301
146,139
154,440
451,558
2,664,282
3,115,840
(321,529)
2,794,311
2,948,751
2,948,751
2,693,087
255,664
2,948,751

The financial statements were approved by the Board of Trustees and authorised for issue on ............................................. and were signed on its behalf by:

............................................. Professor D J Gawkrodger - Trustee

The notes form part of these financial statements

Page 8

British Skin Foundation

Cash Flow Statement for the Year Ended 31 December 2023

Notes
Cash flows from operating activities
Cash generated from operations
22
Net cash provided by operating activities
Cash flows from investing activities
Purchase of tangible fixed assets
Purchase of fixed asset investments
Interest received
Dividends received
Net cash provided by/(used in) investing activities
Change in cash and cash equivalents in
the reporting period
Cash and cash equivalents at the
beginning of the reporting period
Cash and cash equivalents at the end of
the reporting period
31.12.23
£
901,680
901,680
(1,412)
-
9,999
4,684
13,271
914,951
2,664,282
3,579,233
31.12.22
£
298,235
298,235
(1,457)
(49,999)
2,090
2,085
(47,281)
250,954
2,413,328
2,664,282

The notes form part of these financial statements

Page 9

British Skin Foundation

Notes to the Financial Statements for the Year Ended 31 December 2023

1. ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS

British Skin Foundation is a charitable incorporated organisation registered in England. The address of the registered office is given in the report of the trustees, together with details of the charity's operations and principal activities.

The charity constitutes a public benefit entity as defined by FRS 102. The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland issued in October 2019, the Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland (FRS 102), the Charities Act 2011 and UK Generally Accepted Accounting Practice.

The financial statements are prepared on a going concern basis under the historical cost convention, modified to include certain items at fair value. The financial statements are presented in sterling which is the functional currency of the charity and rounded to the nearest £.

The significant accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all years presented unless otherwise stated.

INCOME

All incoming resources are included in the Statement of Financial Activities (SoFA) when the charity is legally entitled to the income and the amount can be measured reliably and it is probable that the income will be received.

EXPENDITURE

Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.

Grants offered subject to conditions which have not been met at the year end date are noted as a commitment but not accrued as expenditure.

FUNDS

Unrestricted funds are available for use at the discretion of the trustees in furtherance of the general objectives of the charity and which have not been designated for other purposes.

Restricted funds are funds which are to be used in accordance with specific restrictions imposed by donors or which have been raised by the charity for particular purposes. The cost of raising and administering such funds are charged against the specific fund. The aim and use of each restricted fund is set out in the notes to the financial statements.

DEBTORS AND CREDITORS RECEIVABLE/PAYABLE WITHIN ONE YEAR

Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in expenditure.

TANGIBLE FIXED ASSETS

Tangible fixed assets are stated at cost (or deemed cost) or valuation less accumulated depreciation and accumulated impairment losses. Cost includes costs directly attributable to making the asset capable of operating as intended.

continued...

Page 10

British Skin Foundation

Notes to the Financial Statements - continued for the Year Ended 31 December 2023

1. ACCOUNTING POLICIES - continued

TANGIBLE FIXED ASSETS

Depreciation is provided on all tangible fixed assets, at rates calculated to write off the cost, less estimated residual value, of each asset on a systematic basis over its expected useful life as follows:

Fixtures and fittings - 10% on cost Computer equipment - 20% on cost

TAXATION

As a registered charity, the organisation is exempt from income and capital gains tax to the extent that its income and gains are applicable to charitable purposes only. Value Added Tax is not recoverable by the charity, and is therefore included within the relevant costs in the Statement of Financial Activities.

EMPLOYEE BENEFITS

When employees have rendered service to the charity, short-term employee benefits to which the employees are entitled are recognised at the undiscounted amount expected to be paid in exchange for that service. The charity operates a defined contribution plan for the benefit of its employees. Contributions are expensed as they become payable.

GOING CONCERN

The financial statements have been prepared on a going concern basis as the trustees believe that no material uncertainties exist. The trustees have considered the level of funds held and the expected level of income and expenditure for 12 months from authorising these financial statements. The budgeted income and expenditure is sufficient with the level of reserves for the charity to be able to continue as a going concern.

INVESTMENTS

Investments are recognised initially at fair value which is normally the transaction price excluding transaction costs. Subsequently, they are measured at fair value with changes recognised in 'net gains/(losses) on investments' in the SoFA if the shares are publicly traded or their fair value can otherwise be measured reliably. Other investments are measured at cost less impairment.

2. DONATIONS AND LEGACIES

Gift aid
Legacies
Donations from individuals
Company donations
Trust donations
BAD Donations
Donations from other charities
Grant donations
SHA donations
31.12.23
£
5,620
55,775
16,145
568,773
419,944
256,000
-
260,716
200,900
1,783,873
31.12.22
£
4,188
98,150
16,624
576,148
499
341,769
30,000
-
201,600
1,268,978

3. OTHER TRADING ACTIVITIES

OTHER TRADING ACTIVITIES
31.12.23 31.12.22
£ £
Fundraising events 42,414 53,499
Sponsorships 12,500 -
54,914 53,499

continued...

Page 11

British Skin Foundation

Notes to the Financial Statements - continued for the Year Ended 31 December 2023

4. INVESTMENT INCOME

INVESTMENT INCOME
31.12.23 31.12.22
£ £
Deposit account interest 12,729 2,505
Dividend income 4,984 4,196
17,713 6,701
RAISING FUNDS
OTHER TRADING ACTIVITIES
31.12.23 31.12.22
£ £
Advertising 12,358 4,594
Events 3,127 1,953
Sponsorships - 446
15,485 6,993

5. RAISING FUNDS

OTHER TRADING ACTIVITIES

6. CHARITABLE ACTIVITIES COSTS

Direct
Costs (see
note 7)
£
Charitable Activities
399,018
Support Costs
-
399,018
DIRECT COSTS OF CHARITABLE ACTIVITIES
Staff costs
Postage and stationery
Travel expenses
Computer expenses
Staff training
Grant
funding of
activities
(see note
8)
£
653,811
-
653,811
Support
costs (see
note 9)
£
-
85,518
85,518
31.12.23
£
351,544
748
1,596
44,752
378
399,018
Totals
£
1,052,829
85,518
1,138,347
31.12.22
£
300,018
5,801
965
40,292
877
347,953

7. DIRECT COSTS OF CHARITABLE ACTIVITIES

continued...

Page 12

British Skin Foundation

Notes to the Financial Statements - continued for the Year Ended 31 December 2023

8. GRANTS PAYABLE

Charitable Activities

31.12.23
£
653,811
31.12.22
£
614,659

The grants paid to Institutions are detailed below:

Ref
7013s
MRC-06
016/s/16
MRC-07
002/yi/17
007/yi/17
016/s/17
025/s/17
026/s/17
MRC-08
011/s/18
024/s/18

030/s/18
032/s/18
036/s/18
037/r/18
043/s/18
MRC-09
099/r/19
002/BSFBAD/19
004/s/19
005/s/19
024/f/19

042/yi/19
044/r/19
045/r/19
022/BSFBAD/20
027/BSFBPG/20
003/s/20
007/s/20
008/r/20
009/r/20
016/s/20
017/s/20
037/r/20
041/s/20
010/BSFSG/21
013/BSFSG/21
014/BSFSG/21
016/BSFSG/21
017/BSFSG/21
004/BSFBPG/21
001/r/21
001/k/21
MRC-10
001/BSFSTART/22
001/LFRSMF/22
002/BSPAD/22
Institution
2023
2022
Trinity College Dublin
-
9,780
Medical Research Council
-
3,548
Queen Mary University of London
26,563
8,854
Medical Research Council
4,762
-
Queen Mary University London
22,500
7,500
University of Bristol
-
(282)
University of Manchester
-
7,087
University of Dundee
3,314
-
University of Edinburgh
-
7,084
Medical Research Council
-
17,841
Queen Mary University London
-
19,917
London School of Hygiene and Tropical
Medicine
-
13,374
Huddersfield University
-
21,109
University College London
6,614
18,763
University of Bath
-
21,250
University of Dundee
180
3,229
Imperial College
28,334
14,167
Medical Research Council
-
5,340
George Kravvas
8,676
71,969
Newcastle University
-
9,960
Beatson Institute for Cancer Research
29,421
31,331
University of Glasgow
21,250
28,333
Guy's and St Thomas' NHS Foundation
Trust
(30,911)
-
King's College London
-
51,205
University of Leeds
30,375
40,500
University College London
-
2,918
Queen Mary University
-
9,900
Guys and St Thomas' NHS Foundation Trust
9,960
-
University of Hull
25,184
16,207
Newcastle University
25,972
13,576
Newcastle University
30,375
20,250
Newcastle University
37,949
17,087
University of Bath
28,333
14,167
University of Birmingham
42,500
-
University of Manchester
40,500
10,125
University of Nottingham
28,333
14,167
Trinity College Dublin
-
10,000
University of Manchester
-
10,000
Cardiff University
-
10,000
South Warwick University
-
10,000
St George's Hospital
9,876
-
St Vincent's Foundation
-
8,188
University of Southampton
40,129
-
University of Dundee
46,065
-
Medical Research Council
27,083
-
University College London
2,640
6,215
King's College London
-
30,000
Oxford University
10,000
-

continued...

Page 13

British Skin Foundation

Notes to the Financial Statements - continued

for the Year Ended 31 December 2023

8. GRANTS PAYABLE - continued

004/SG/22
University of Bradford
9,993
011/SG/22
University of Bath
9,500
014/SG/22
University of Birmingham
9,945
016/SG/22
Anglia Ruskin University
9,984
018/SG/22
University of Leeds
10,000
023/yi/22
University of Manchester
10,041
028/s/22
University of Cambridge
5,386
034/yi/22
University of Oxford
12,988
011/BSFBAD/23
Newcastle University
9,997
002/BSFBSPAD/23
Royal Marsden NHS Foundation Trust
10,000
£ 653,811
-
-
-
-
-
-
-
-
-
-
£ 614,659

9. SUPPORT COSTS

Management
£
Support Costs
68,026
Support costs, included in the above, are as follows:
Trustees' remuneration etc
Insurance
Exchange rate
Sundries
Office accommodation charges
Subscriptions
Depreciation of tangible and heritage assets
Bank charges
HMRC interest
Payroll costs
Auditors' remuneration
Auditors' remuneration for non audit work
Legal fees
Governance
Finance
costs
Totals
£
£
£
3,404
14,088
85,518
31.12.23
31.12.22
Support
Total
Costs
activities
£
£
575
170
3,099
1,528
3,109
-
1,129
1,220
56,000
56,000
2,396
3,386
1,718
1,534
1,845
2,288
-
5
1,559
1,219
7,506
6,054
6,582
6,618
-
1,764
85,518
81,786

continued...

Page 14

British Skin Foundation

Notes to the Financial Statements - continued for the Year Ended 31 December 2023

10. NET INCOME/(EXPENDITURE)

Net income/(expenditure) is stated after charging/(crediting):

31.12.23 31.12.22
£ £
Auditors' remuneration 7,506 6,054
Auditors' remuneration for non audit work 6,582 6,618
Depreciation - owned assets 1,719 1,533
(Profit)/loss on fair value movement of investments (5,493) 15,301

11. TRUSTEES' REMUNERATION AND BENEFITS

There were no trustees' remuneration or other benefits for the year ended 31 December 2023 nor for the year ended 31 December 2022.

TRUSTEES' EXPENSES

During the year ended 31 December 2023, expenses totalling £575 (2022: £170) were reimbursed to 1 Trustees (2022: 1) for travel costs.

12. STAFF COSTS

Wages and salaries
Social security costs
Other pension costs
The average monthly number of employees during the year was as follows:
Administration and management
31.12.23
£
308,220
27,937
15,387
351,544
31.12.22
£
261,030
25,146
13,842
300,018
31.12.23
8
31.12.22
7

The average monthly number of employees during the year was as follows:

Administration and management

The number of employees whose employee benefits (excluding employer pension costs) exceeded £60,000 was:

31.12.23 31.12.22
£60,001 - £70,000 1 -
£70,001 - £80,000 1 2
2 2

continued...

Page 15

British Skin Foundation

Notes to the Financial Statements - continued

for the Year Ended 31 December 2023

13. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES

Unrestricted
Restricted
fund
fund
£
£
INCOME AND ENDOWMENTS FROM
Donations and legacies
1,202,295
66,683
Other trading activities
53,499
-
Investment income
6,701
-
Total
1,262,495
66,683
EXPENDITURE ON
Raising funds
6,993
-
Charitable activities
Charitable Activities
793,752
168,860
Support Costs
81,786
-
Total
882,531
168,860
NET INCOME/(EXPENDITURE)
379,964
(102,177)
Other recognised gains/(losses)
Gains/(losses) on revaluation of fixed assets
(15,031)
-
Net movement in funds
364,933
(102,177)
RECONCILIATION OF FUNDS
Total funds brought forward
2,328,154
357,841
TOTAL FUNDS CARRIED FORWARD
2,693,087
255,664
14.
TANGIBLE FIXED ASSETS
Fixtures
and
Computer
fittings
equipment
£
£
COST
At 1 January 2023
7,109
4,113
Additions
978
434
At 31 December 2023
8,087
4,547
DEPRECIATION
At 1 January 2023
1,276
1,645
Charge for year
809
910
At 31 December 2023
2,085
2,555
NET BOOK VALUE
At 31 December 2023
6,002
1,992
At 31 December 2022
5,833
2,468
Total
funds
£
1,268,978
53,499
6,701
1,329,178
6,993
962,612
81,786
1,051,391
277,787
(15,031)
262,756
2,685,995
2,948,751
Totals
£
11,222
1,412
12,634
2,921
1,719
4,640
7,994
8,301

continued...

Page 16

British Skin Foundation

Notes to the Financial Statements - continued for the Year Ended 31 December 2023

15. FIXED ASSET INVESTMENTS

FIXED ASSET INVESTMENTS
Listed
investments
£
MARKET VALUE
At 1 January 2023 146,139
Revaluations 5,493
At 31 December 2023 151,632
NET BOOK VALUE
At 31 December 2023 151,632
At 31 December 2022 146,139

There were no investment assets outside the UK.

The fair value of listed investments is determined by reference to the quoted price for identical assets in an active market at the balance sheet date.

16. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
Accrued interest
Other donations
Accrued dividend
Accrued income
Accrued gift aid
Prepayments
Gift aid recoverable
31.12.23
£
1,849
74,118
3,259
-
5,589
44,362
18,000
147,177
31.12.22
£
484
338,000
3,109
54,000
-
37,965
18,000
451,558

17. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Grant payables
Trade creditors
Other creditors
Credit card
Accruals
Accrued expenses
Deferred income
31.12.23
£
120,244
22,963
2,188
352
13,200
677
69,500
229,124
31.12.22
£
119,000
17,672
-
208
11,352
297
173,000
321,529

continued...

Page 17

British Skin Foundation

Notes to the Financial Statements - continued for the Year Ended 31 December 2023

18. MOVEMENT IN FUNDS

Unrestricted
Restricted
Unrestricted
Restricted
Balance at 1st
January 2023
£
2,693,087
255,664
2,948,751
Balance at 1st
January 2022
£
2,328,154
357,841
2,685,995
Income
£
1,313,028
543,472
1,856,500
Income
£
1,262,495
66,682
1,329,178
Expenditure
£
(972,551)
(181,281)
(1,153,832)
Expenditure
£
(882,531)
(168,860)
(1,051,391)
Transfers
£
-
-
-
Transfer s
£
-
-
-
Gains/(losses)
£
5,493
-
5,493
Gains/(losses)
£
(15,031)
-
(15,031)
Balance at 31st
December 2023
£
3,039,057
617,855
3,656,912
Balance at 31st
December 2022
£
2,693,087
255,664
2,948,751

Fund description

a) Unrestricted funds

Unrestricted funds are available to spend on activities that further any purpose of the charity.

b) Restricted funds

Donations received to be used to fund specific skin disease research projects.

19. PENSIONS AND OTHER POST RETIREMENT BENEFITS

The charity operates a defined contribution pension plan for its employees. The amount recognised as an expense in the period was £15,387 (2022 - £13,842).

The defined contribution liability is allocated to unrestricted funds and is a direct cost within charitable activities.

20. FINANCIAL COMMITMENTS

£2,539,209 of grant funding commitments have not been accrued in the balance sheet as performance related conditions have not been met. The charity holds sufficient cash deposits to fund these grant commitments. There is uncertainty as to when these commitments will be settled, as they depend on the progress of each medical research project.

Grant commitments as at 31st December 2023:

Ref Total value Outstanding
2016 MRC-06 55,000 1,100
2017 025/s/17 85,000 38,879
2018 MRC-08 58,028 1,879
024/s/18 85,000 13,363
032/s/18 85,000 3,531
037/r/18 75,197 34,899
043/s/18 85,000 7,083

continued...

Page 18

British Skin Foundation

Notes to the Financial Statements - continued

for the Year Ended 31 December 2023

20. FINANCIAL COMMITMENTS - continued

2019 MRC-09 63,435 5,340
099/r/19 170,000 21,766
009/BSFBPG/19 10,000 10,000
004/s/19 85,000 208
042/yi/19 79,902 23,617
2020 021/BSFSG/20 10,000 10,000
003/s/20 85,000 43,609
007/s/20 85,000 45,451
008/r/20 81,000 30,375
009/r/20 80,200 25,163
011/yi/20 89,978 89,978
016/s/20 85,000 37,700
017/s/20 85,000 42,500
025/s/20 85,000 85,000
037/r/20 81,000 30,375
041/s/20 85,000 42,500
2021 019/BSFBAD/21 10,000 10,000
001/r/21 40,500 371
2022 MRC-10 65,000 37,917
001/BSFSTART/22 50,000 38,458
021/BSMD/22 9,994 9,994
006/r/22 80,406 80,406
008/s/22 85,000 85,000
009/s/22 85,000 85,000
012/r/22 39,766 39,766
014/s/22 85,000 85,000
021/s/22 85,000 85,000
023/yi/22 80,325 70,284
028/s/22 85,000 79,614
034/yi/22 89,862 76,873
037/r/22 80,839 80,839
2023 002/BSFSG/23 9,900 9,900
007/BSFSG/23 9,997 9,997
009/BSFSG/23 10,000 10,000
010/BSFSG/23 10,000 10,000
014/BSFSG/23 10,000 10,000
019/BSFSG/23 9,939 9,939
002/BSFBAD/23 10,000 10,000
003/BSFBAD/23 9,991 9,991
001/f/23 62,000 62,000
002/f/23 62,000 62,000
002/s/23 95,000 95,000
003/r/23 80,544 80,544
003/s/23 95,000 95,000
004/r/23 81,000 81,000
004/s/23 95,000 95,000
005/s/23 95,000 95,000
008/s/23 95,000 95,000
009/s/23 95,000 95,000
011/s/23 95,000 95,000
Total £ 2,539,209

continued...

Page 19

British Skin Foundation

Notes to the Financial Statements - continued for the Year Ended 31 December 2023

21. RELATED PARTIES

The British Skin Foundation Chief Executive is the sole owner and Managing Director of the Skin Health Alliance (Company Registration No. 07445820). The Skin Health Alliance donated £200,900 to the British Skin Foundation in 2023 (2022: £201,600).

Dr Tamara Griffiths was a trustee of the British Association of Dermatology ("BAD") and the British Skin Foundation during 2023. The charity received donations totalling £256,000 from British Association of Dermatology ("BAD") in 2023 (2022: £341,769).

22. RECONCILIATION OF NET INCOME TO NET CASH FLOW FROM OPERATING ACTIVITIES

Net income for the reporting period (as per the Statement of Financial
Activities)
Adjustments for:
Depreciation charges
(Gains)/losses on investments
Interest received
Dividends received
Decrease/(increase) in debtors
(Decrease)/increase in creditors
Net cash provided by operations
31.12.23
£
708,161
1,719
(5,493)
(11,364)
(4,834)
305,896
(92,405)
901,680
31.12.22
£
262,756
1,533
15,031
(2,505)
(4,196)
(52,014)
77,630
298,235

23. ANALYSIS OF CHANGES IN NET FUNDS

Net cash
Cash at bank and in hand
Total
At 1.1.23
£
2,664,282
2,664,282
2,664,282
Cash flow
£
914,951
914,951
914,951
At 31.12.23
£
3,579,233
3,579,233
3,579,233

Page 20